41. Physicians Dialysis, Inc.: Understanding End Stage Renal Disease (ESRD) endstage renal disease(ESRD)occurs when the kidney no longer function.With ESRD, normal kidney function does not return. There http://www.phydial.com/renalcare.html

We work closely with our patients to help them understand their condition and treatment options, so they can be comfortable with their care. Learning about dialysis and the various treatment modalities. The kidneys are located below the rib cage in the middle of the back. The function of the kidneys is to filter the blood and form urine. The kidneys have four major functions: Remove waste products from the blood Remove extra fluid Adjust levels of minerals and other chemicals Produce hormones When the kidneys fail they can no longer remove the wastes and extra fluid from the body. This causes the patient to feel sick. There are many reasons why kidneys fail. Some kidney diseases are inherited, while others are caused by other underlying health problems. Some causes include: diabetes, hypertension, glomerulonephritis or nephritic syndrome. End-Stage Renal Disease (ESRD) occurs when the kidney no longer function. With ESRD, normal kidney function does not return. There are three treatment options that should be considered including: hemodialysis, peritoneal dialysis or transplantation. The patient’s nephrologists and renal care team will meet with the patient and family to guide them through the process of selecting the best treatment modality that meets the patient’s needs and life choices.

42. End Stage Renal Disease Kidney. End Stage Renal Disease. End stage kidney failure. End StageRenal Disease What are renal failure and endstage renal disease? http://jhhs.client.web-health.com/web-health/topics/GeneralHealth/generalhealths

43. EMR Textbook - End-Stage Renal Disease endstage renal disease. References. 1. Port FK. Worldwide demographics and internationaltrends in end stage renal disease. Kidney Int 1993;43S4-S7. http://www.thrombosis-consult.com/articles/Textbook/150_renal.htm

End-Stage Renal Disease Walter G. Belleza, MD The patient with end-stage renal disease (ESRD) is a diagnostic and therapeutic challenge for the emergency physician. Clinical presentations range from the nearly asymptomatic patient with laboratory evidence of mild hyperkalemia to the patient with fulminate pulmonary edema or cardiac arrest. Within a narrow window of time and with limited data, the emergency physician must initiate potentially treacherous therapeutic maneuvers for a patient functioning within narrow metabolic boundaries. By definition, ESRD occurs when a patient’s kidneys can no longer sustain life without the aid of dialysis therapy or a renal transplant. It is at the end point of chronic renal failure where the majority of clinical complications occur. Chronic renal failure (CRF) implies that an irreversible reduction in renal function exists, and recovery of that function is unlikely. Nearly every organ system suffers in ESRD. If profound enough and not treated accordingly, ESRD results in the uremic syndrome. The uremic syndrome is a constellation of multisystemic complications that result from the accumulation of nitrogenous wastes and metabolic by-products. Symptoms may range from fluid overload and congestive heart failure to encephalopathy and coma. To prevent this and other systemic derangements, patients are started on either peritoneal dialysis or hemodialysis. Dialysis therapy can be life-saving but can also cause its own complications. In this chapter, the authors review the complex constellation of problems associated with ESRD from the perspective of the emergency physician.

44. End-Stage Renal Disease Attributable To..., Annals 15 Dec 94 endstage renal disease Attributable to Diabetes Mellitus. Annals of Internal Medicine,15 December 1994; 121 912-918. Odds Ratios of end-stage renal disease. http://www.acponline.org/journals/annals/15dec94/renal.htm

Annals of Internal Medicine Current Issue Past Issues Library for Internists Subscriptions ... Email this page Annals of Internal Medicine End-Stage Renal Disease Attributable to Diabetes Mellitus Annals of Internal Medicine , 15 December 1994; 121: 912-918. Thomas V. Perneger, MD, PhD; Frederick L. Brancati, MD, MHS; Paul K. Whelton, MD, MSc; and Michael J. Klag, MD, MPH Objective: To determine the proportion of end-stage renal disease associated with diabetes mellitus in a biracial population, using population-attributable risk estimates. Design: Case-control study. Setting: Population-based study in Maryland, Virginia, West Virginia, and Washington, D.C. Participants: 716 newly treated patients with kidney failure aged 20 to 64 years and 361 age-matched controls. Measurements: Self-reported history of diabetes mellitus, including type, duration, treatment, and complications. Results: Persons with insulin-dependent diabetes (odds ratio, 33.7) and non-insulin-dependent diabetes (odds ratio, 7.0) were at greater risk for end-stage renal disease than were persons without diabetes. The odds ratio was only slightly increased for diabetes lasting less than 15 years, but the ratio increased more than 20-fold for diabetes lasting 15 years or more. The population-attributable risk for kidney failure was 21% for insulin-dependent diabetes and 21% for non-insulin-dependent diabetes (42% overall). A similar proportion of end-stage renal disease was attributed to diabetes in whites (44%) and in blacks (41%). Insulin-dependent diabetes had a relatively greater effect on the incidence of kidney failure in whites; in contrast, non-insulin-dependent diabetes had a relatively greater effect on kidney failure in blacks.

45. Insuficiencia Renal Crónica Terminal - End-Stage Renal Disease - ESRD - Choosin end-stage renal disease (ESRD). http://diabetes.about.com/library/blespanol/blspNIHesrd.htm

zfp=-1 About Diabetes Search in this topic on About on the Web in Products Web Hosting Diabetes with Paula Ford-Martin Your Guide to one of hundreds of sites Home Articles Forums ... Help zmhp('style="color:#fff"') Subjects ESSENTIALS Carbs and Diabetes About Diabetes Recipe Box Tools for Diabetes Control ... All articles on this topic Stay up-to-date! Subscribe to our newsletter. Advertising Free Credit Report Free Psychics Advertisement Insuficiencia Renal Crónica Terminal Cuando los riñones fallan Hemodiálisis Diálisis peritoneal Trasplante de riñón ... Material de lectura adigional Este folleto está dirigido a aquellas personas cuyos riñones han dejado de funcionar. Este estado se llama insuficiencia renal crónica terminal, o en inglés "end-stage renal disease" (ESRD). En la actualidad hay tratamientos nuevos y mejorados para la ESRD que sustituyen la función de los riñones sanos. Conociendo cuáles son las alternativas de tratamiento, Ud. puede colaborar con su médico para elegir la que más le beneficia. Cualquiera sea el tratamiento que Ud. elija, experimentará algunos cambios en su vida. Pero con la ayuda de su equipo de atención médica, de su familia y de sus amigos, podrá llevar una vida plena y activa. Este folleto describe las alternativas de tratamiento: hemodiálisis, diálisis peritoneal y trasplante de riñón. Informa sobre los pros y contras de cada uno. También trata de la dieta y del pago del tratamiento. Aconseja cómo colaborar con el médico, las enfermeras y los demás miembros de su equipo de atención médica. Proporciona una lista de los grupos que ofrecen información y servicios a los enfermos renales. También enumera las revistas, libros y folletos que Ud. puede leer para obtener mayor información acerca del tratamiento.

46. Acute Hepatitis HCV Infection In End-Stage Renal Disease Patients Acute Hepatitis HCV Infection in endstage renal disease Patients AcuteHCV infection does not occur frequently. However, end-stage http://www.hivandhepatitis.com/hep_c/news/012903d.html

Acute Hepatitis HCV Infection in End-Stage Renal Disease Patients Acute HCV infection does not occur frequently. However, end-stage renal disease (ESRD) patients on chronic hemodialysis, due to the constant parenteral exposition, remain at risk for this condition. The early diagnosis and treatment of the acute infection decrease the risk of HCV chronic evolution. The aim of the present study was to describe clinical, laboratorial and virological features of acute HCV infection in ESRD patients on chronic hemodialysis. Patients on chronic hemodialysis presenting acute increase of ALT levels followed by anti-HCV seroconversion were included between March1999 and May 2002. Both are done monthly in the dialysis centers. HCV-RNA and genotyping were performed by Amplicor (Roche) and sequencing methods, respectively. At the time of the acute HCV infection diagnosis, the duration of hemodialysis treatment, the presence of signs or symptoms and the ALT features (peak levels and the length between the ALT peak level and anti-HCV seroconversion) were analyzed.

47. END-STAGE RENAL DISEASE IN AFRICAN-AMERICAN MEN endstage renal disease IN AFRICAN-AMERICAN MEN ASSOCIATED WITH HIGHBLOOD PRESSURE AND LOWER INCOME. April 23, 1997 Media Contact http://www.hopkinsmedicine.org/press/1997/APRIL/199713.HTM

END-STAGE RENAL DISEASE IN AFRICAN-AMERICAN MEN ASSOCIATED WITH HIGH BLOOD PRESSURE AND LOWER INCOME April 23, 1997 Media Contact: Gary Stephenson Phone: (410)955-5384 E-mail: gstephen@welchlink.welch.jhu.edu Although hypertension and low income already are linked to an increased risk of end-stage renal disease (ESRD) for both African-American and white men, the two factors may help explain the four-fold higher incidence of ESRD found in blacks, compared to whites, according to a study led by Johns Hopkins researchers published in the April 23 issue of The Journal of the American Medical Association. These results also may help physicians design more effective treatment strategies, says Michael J. Klag, M.D., Hopkins associate professor of medicine and principal investigator for the study. "These results indicate that interventions designed to address the markedly higher incidence of end-stage renal disease in African-American men need to focus on ethnic disparities in blood pressure and socioeconomic status," he says. In the study, data were analyzed from 332,544 men (300,645 white, 20,222 African-American, 11,677 other ethnic groups) aged 35 to 57 years who had been screened for the Multiple Risk Factor Intervention Trial, a study designed to examine the effects of various interventions on coronary heart disease. The incidence of ESRD was assessed using the Health Care Financing Administration national ESRD Treatment Registry. Death from renal disease was assessed using data from the National Death Index and the Social Security Administration.

48. JAMA -- Page Not Found and Mortality Weekly Report endstage renal disease Attributed to Diabetes AmongAmerican Indians/Alaska Natives With Diabetes United States, 1990-1996 MMWR. http://jama.ama-assn.org/issues/v285n1/ffull/jwr0103-3.html

Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery MSJAMA Science News Updates Meetings Peer Review Congress The page you requested was not found. The JAMA Archives Journals Web site has been redesigned to provide you with improved layout, features, and functionality. The location of the page you requested may have changed. To find the page you requested, click here HOME CURRENT ISSUE PAST ISSUES ... HELP Error 404 - "Not Found"

49. END-STAGE RENAL DISEASE (ESRD) PROGRAM State of Hawaii Department of Health Office of Health Care Assurance MedicareSection. end-stage renal disease (ESRD) PROGRAM. HAWAII FACILITY. LOCATION. 1. http://www.state.hi.us/health/resource/ohca/medicare/renal/directory-renal.html

State of Hawaii - Department of Health Office of Health Care Assurance Medicare Section END-STAGE RENAL DISEASE (ESRD) PROGRAM HAWAII: FACILITY LOCATION FRESENIUS MEDICAL CARE - ALOHA DIALYSIS CENTER 1520 Liliha Street Honolulu, Hawaii 96817 Mailing Address: 226 North Kuakini Street Honolulu, Hawaii 96817 Ph: (808) 531-1748 Fax: (808) 531-1501 Alvin Cecil, Regional Manager Provider No. 122503 OAHU FRESENIUS MEDICAL CARE - DIALYSIS SERVICES OF KAPOLEI 555 Farrington Highway Kapolei, Hawaii 96707 Ph: (808) 693-8980 Fax: (808) 693-8968 Alvin Cecil, Regional Manager Provider No. 122508 OAHU FRESENIUS MEDICAL CARE - DIALYSIS SERVICES OF PEARLRIDGE 98-1005 Moanalua Road, Suite 420 Aiea, Hawaii 96701 Ph: (808) 440-4800 Fax: (808) 440-4827 Roberta Lovely, Administrative Director Provider No. 122509 OAHU FRESENIUS MEDICAL CARE - HONOLULU DIALYSIS CENTER 226 North Kuakini Street Honolulu, Hawaii 96817 Ph: (808) 545-3933 Fax: (808) 545-2971 Alvin Cecil, Regional Manager Provider No. 122501 OAHU FRESENIUS MEDICAL CARE - LANAI COMMUNITY DIALYSIS CENTER th Street Lanai City, Hawaii 96763

50. NEJM -- Sign In Next Next. Prevention of endstage renal disease Due to Type 2 Diabetes. Theprevalence of end-stage renal disease is increasing at an alarming rate. http://content.nejm.org/cgi/content/short/345/12/910

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP The full text of the Journal is available online for all subscribers to the print version. For Original Articles and Special Articles, six months after publication the full text becomes available to all registered users. Registered Users User Name Password Remember my user name and password. Forgotten the password? If you do not use cookies sign in here If you have purchased access to an article or the Journal website, you may regain access here First-Time Users If you are a Journal subscriber using the Journal On-line for the first time, you must register and choose a password. If you are not a Journal subscriber subscribe here If you would like full access to the Journal Web site for 24 hours for $29, click here To regain access to Journal Web site, click here If you would like full access to this article for $10, click here To regain access to a purchased article, click here If you would like free full access to all Original Articles and Special Articles beginning six months after publication register here If you cannot get past this page

51. End-Stage Renal Disease End Stage Renal Disease. End Stage Renal Disease This conditionis called end-stage renal disease (ESRD). Today, there are http://www.health-nexus.com/end-stage_renal_disease.htm

Health-Nexus.Net Health-Nexus.Org The #1 Health information site Home ... Up Search Health-Nexus for: Match ALL words Match ANY word Email this page to a friend ! Post a question or comment on our Message Board Home Page Health Specialties Health News ... Alternative Health Options Substance Abuse Animal Health Search: Books Magazines Video Keywords: Find it Here End Stage Renal Disease End Stage Renal Disease RENALNET Features End Stage Renal Disease Clinical Practice Tools Thanks to our sponsor: New Site Highlight Clinical Practice Tools The purpose of the Core Indicators Project is to assist providers of ESRD services. End-Stage Renal Disease: Choosing a Treatment That's Right This e-text is for people whose kidneys fail to work. This condition is called end-stage renal disease (ESRD). Today, there are ... HealthGate's Kidney Disease Center Health and medical information, including end stage renal disease, kidney infections and kidney stones. End-Stage Renal Disease END-STAGE RENAL DISEASE What causes End-Stage Renal Disease? Is there a cure or treatment for ESRD? Who is most at risk for ESRD? See also... Kidney Disease Diabetes Each year in the United States, ....

52. Arch Intern Med -- Page Not Found endstage renal disease in Specific Ethnic and Racial Groups Risk Factors and Benefitsof Antihypertensive Therapy Author Information David R. Powers, MD; J http://archinte.ama-assn.org/issues/v158n7/abs/ira60346.html

Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery MSJAMA Science News Updates Meetings Peer Review Congress The page you requested was not found. The JAMA Archives Journals Web site has been redesigned to provide you with improved layout, features, and functionality. The location of the page you requested may have changed. To find the page you requested, click here HOME CURRENT ISSUE PAST ISSUES ... HELP Error 404 - "Not Found"

53. ESC Losartan Reduces Incidence Of End-Stage Renal Disease In ESC Losartan Reduces Incidence of endstage renal disease in Type 2Diabetics, Also Lowers Cost Burden By Ed Susman Special to DG News http://www.pslgroup.com/dg/21cd4e.htm

54. Wisconsin Medicaid Provider Type: 73 End-Stage Renal Disease Service Providers ServiceSpecific Publications for End Stage Renal Disease Service Providers. Providerspecialties for End Stage Renal Disease Service providers. http://www.dhfs.state.wi.us/medicaid/updates/provtype/73renaldis.htm

Licensing Reference Center Search Provider Home ... Related Programs/Services Service-Specific Publications for End Stage Renal Disease Service Providers Most Wisconsin Medicaid publications — handbooks Updates and reference materials — for End Stage Renal Disease Service Providers are listed below. In addition to these publications, providers should refer to the All-provider Updates and current Remittance and Status messages Some of these publications are available only as PDFs. You will need Adobe Acrobat Reader to view these files. Publication Description of Publication Date Released or Revised Handbooks and Guides All-Provider Handbook This All-Provider Handbook (formerly known as Part A) is issued to all providers who are Wisconsin Medicaid certified. Wisconsin Medicaid is also known as Medical Assistance (MA), the Medical Assistance Program (WMAP), Title XIX, or T19. This handbook contains information that applies to fee-for-service Medicaid providers.

55. PhosLo By Braintree Labs: Binder For End-Stage Renal Disease PhosLo PhosLo is a prescription phosphate binder indicated for the controlof hyperphosphatemia in end stage renal failure. Learn More, http://www.phoslo.com/

PhosLo PhosLo is a prescription phosphate binder indicated for the control of hyperphosphatemia in end stage renal failure. Created By PixelMEDIA, Inc. PhosLo is indicated for control of hyperphosphatemia in end-stage renal failure. Patients with higher-than-normal serum calcium levels should be closely monitored and their dose adjusted or terminated to bring levels to normal. PhosLo is contraindicated in patients with hypercalcemia. No other calcium supplements should be given concurrently with PhosLo.

56. Urology - End Stage Renal Disease (ESRD) endstage renal disease (ESRD) What is renal failure? Renal failurerefers What is end-stage renal disease (ESRD)? End-stage renal http://www.viahealth.org/disease/urology/endstage.htm

ViaHealth Disease and Wellness Information End-Stage Renal Disease (ESRD) What is renal failure? Renal failure refers to temporary or permanent damage to the kidneys that results in loss of normal kidney function. There are two different types of renal failure - acute and chronic. Acute renal failure has an abrupt onset and is potentially reversible. Chronic failure progresses slowly over at least three months and can lead to permanent renal failure. The causes, symptoms, treatments, and outcomes of acute and chronic are different. Conditions that may lead to acute or chronic renal failure may include, but are not limited to, the following: Acute Renal Failure Chronic Renal Failure Myocardial infarction - a heart attack may lead to temporary kidney failure. Diabetic nephropathy - diabetes can cause permanent changes, leading to kidney damage. Rhabdomyolysis - kidney damage that can occur from muscle breakdown. This condition can occur from severe dehydration, infection, or other causes.

57. PREVENTION OF END-STAGE RENAL DISEASE DUE TO TYPE 2 DIABETES SanofiSynthelabo. PREVENTION OF end-stage renal disease DUE TO TYPE 2 DIABETES. Theprevalence of end-stage renal disease is increasing at an alarming rate. http://www.sanofi-synthelabo.com.ph/news/news_092001_1.shtml

PREVENTION OF END-STAGE RENAL DISEASE DUE TO TYPE 2 DIABETES Reprinted From The New England Journal of Medicine - September 20, 2001 The prevalence of end-stage renal disease is increasing at an alarming rate. In 2000, chronic kidney failure developed in ver 90, 000 people in the United States; the current population of patients no dialysis numbers about 300, 000, and 80, 000 patients are living with transplanted kidneys. Both the prevalence and the incidence of end-stage renal disease are approximately twice what they were 10 years ago. Indeed, in 2000, the number of patients with newly diagnosed renal failure exceeded the number who died of any single type of cancer except lung cancer. Nephropathy due to type 2 diabetes accounts for almost all of the increasing number of patients with kidney failure. If the trends of the past two decades persist, approximately 175, 000 new cases of uremia will be diagnosed in 2010. Since the number of kidney transplantations has all but stalled at about 13, 000 per year, the majority of these patients will be treated with dialysis. Improvements in dialysis and transplantation are surely needed. However, caring for patients with end-stage renal disease already consumes more than $18 billion per year in the United States. Six percent of the Medicare budget is used for this service. Shortages of nursing and technical staff for dialysis centers are currently severe, and a shortage of nephrologists is projected. Hence, the prevention of end-stage renal disease is critical. Type 2 diabetes itself may be preventable. Glycemic and blood-pressure control blunt its renal complications.

58. Overview, Cincinnati Childrens Hospital Medical Center endstage renal disease care program. Overview Children's Hospital MedicalCenter of Cincinnati has cared for children with end-stage http://www.cincinnatichildrens.org/Services/Programs_And_Services/End-Stage_Rena

Services / Programs Overview Why Choose Us? Faculty and Staff End-Stage Renal Disease Care Program Overview Children's Hospital Medical Center of Cincinnati has cared for children with end-stage renal disease for more than 30 years, and our nephrologists and surgeons are in the forefront of clinical research for children with end-stage renal disease. Areas of Emphasis Managing children whose renal failure is accompanied by severe congenital anomalies and/or bladder dysfunction. Using a team approach to nutrition, growth promotion, and staged surgical repair, with attention to maintaining access to dialysis, the end-stage renal disease team has successfully rehabilitated a number of children with devastating anomalies. Staged surgical procedures, including bladder augmentation or replacement; creation of a Mitrofanoff neourethra; urinary and bowel incontinence repairs; and nephrectomy. Developing and monitoring clinical guidelines for childhood renal transplantation. End-Stage Renal Disease Program Highlights One of the first in the United States to provide comprehensive end-stage renal disease services for children;

59. RMS Disease Management Provider of renal disease management services nationwide to improve the care and outcomes of endstage renal patients (ESRD) while managing costs. http://www.rmshealthsystems.com

60. VISION - End Stage Renal Disease (ESRD) Network 13 - Serving Arkansas, Louisiana End Stage renal disease (ESRD) Network 13. End Stage renal disease (ESRD)Network 13. Serving Arkansas, Louisiana and Oklahoma renal Communities. http://www.network13.org/vision.htm

End Stage Renal Disease (ESRD) Network 13 Serving Arkansas, Louisiana and Oklahoma Renal Communities About Us Grievance Policy Links Privacy Policy ... home page Prepared by ESRD Network 13 VISION QualityNet Echange Web site http://www.qnetexchange.org http: Consolidated Renal Operations in a Web Enabled Network (CROWN) in order to improve data management for the Medicare End Stage Renal Disease (ESRD) Program. The VISION (Vital Information System to Improve Outcomes in Nephrology) software application will support electronic data entry and encrypted transmission of ESRD patient and facility data from dialysis and transplant facilities directly to their Networks via a secure, Web-enabled environment called "QualityNet Exchange" Listed below are the roles that your facility would be expected to perform while utilizing this product, as well as the benefits that will come with implementing this product. Benefits of Participating: Ability to track patients in a centralized database.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 90    Back | 1  | 2  | 3  | 4  | 5  | Next 20